Patents by Inventor Thibaut LABOUTE

Thibaut LABOUTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETING GPR158 (MGLYR) WITH NANOBODIES FOR THERAPEUTIC BENEFITS
    Publication number: 20260193347
    Abstract: The invention provides antibodies that specifically bind GPR158 and inhibit GAP activity of GPR158 via RGS7/G?5. The antibodies are useful in the diagnosis and treatment of affective disorders, mood disorders, and brain disorders.
    Type: Application
    Filed: November 28, 2023
    Publication date: July 9, 2026
    Inventors: Kirill MARTEMYANOV, Thibaut LABOUTE